by Jeito Life | 14 Dec Mon | English
Jeito’s third international investment in H2 2020, with deep and rapidly accelerating pipeline Therachon’s Founder, Elvire Gouze, launches latest new gene therapy company in her field of excellence €20 million Series A financing, sees Jeito co-investing again with...
by Jeito Life | 13 Nov Fri | English
Paris, France, 13 November 2020 – Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated to biotech and biopharma, today announced that Sanofi has made a €50 million investment in Jeito Capital. The investment will be deployed by Jeito’s highly...
by Jeito Life | 21 Oct Wed | English
Jeito Capital has selected SparingVision as its first French investment following the fund I launch in January 2020 SparingVision is focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases Paris,...
by Jeito Life | 30 Sep Wed | English
Paris, France, 30 September 2020 – Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated to biotech and biopharma, today announced that Rafaèle Tordjman, Founder and CEO of Jeito, has been awarded Chevalier de la Légion d’Honneur. The Légion...
by Jeito Life | 15 Sep Tue | English
Neogene becomes Jeito Capital’s first investment following the fund I launch in January 2020 Round co-led by Jeito Capital alongside EcoR1 Capital and Syncona; with support from Neogene Therapeutics’ strategic seed investors Vida Ventures, TPG Capital and Two River...
Recent Comments